AMAG Pharmaceuticals CEO William Heiden's 2018 pay rises 14% to $5M
AMAG Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 12, 2019
AMAG Pharmaceuticals reported fiscal year 2018 executive compensation information on April 12, 2019.
In 2018, six executives at AMAG Pharmaceuticals received on average a compensation package of $2.2M, a 16% increase compared to previous year.
Average pay of disclosed executives at AMAG Pharmaceuticals
William K. Heiden, Chief Executive Officer, received $5M in total, which increased by 14% compared to 2017. 45% of Heiden's compensation, or $2.2M, was in stock awards. Heiden also received $880K in non-equity incentive plan, $1.1M in option awards, $781K in salary, as well as $11K in other compensation.
For fiscal year 2018, the median employee pay was $195,142 at AMAG Pharmaceuticals. Therefore, the ratio of William K. Heiden's pay to the median employee pay was 25 to one.
J. Alan Butcher, Chief Business Officer and Executive Vice President, received a compensation package of $2.1M. 32% of the compensation package, or $657K, was in option awards.
Julie Krop, Chief Medical Officer, earned $1.6M in 2018, a 28% increase compared to previous year.
Nicholas Grund, Former Chief Commercial Officer, received $1.6M in 2018, which increases by 8% compared to 2017.
Edward Myles, Chief Financial Officer, earned $1.5M in 2018, a 20% increase compared to previous year.
Joseph D. Vittiglio, General Counsel, received $1.5M in 2018, which increases by 24% compared to 2017.
Related executives
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
J Butcher
AMAG Pharmaceuticals
Chief Business Officer and Executive Vice President
Nicholas Grund
AMAG Pharmaceuticals
Former Chief Commercial Officer
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
Joseph Vittiglio
AMAG Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on April 12, 2019.